论文部分内容阅读
目的探讨氯吡格雷与灯盏细辛注射液治疗急性脑梗死的临床效果。方法选择2014年9月至2015年3月经头颅CT证实符合诊断标准的急性脑梗死患者60例,根据治疗方案分为两组,每组30例,对照组口服氯吡格雷,干预组加用灯盏细辛注射液,比较两组患者的临床疗效。结果干预组总有效率(93.3%)高于对照组(66.7%),差异有统计学意义(χ2=5.104,P<0.05)。治疗后干预组NIHSS评分低于对照组,差异有统计学意义(P<0.05)。结论灯盏细辛注射液及氯吡格雷治疗急性脑梗死能够显著提高其临床疗效,改善神经功能缺损,值得临床推广应用。
Objective To investigate the clinical effect of clopidogrel and erigeron breviscapus injection on acute cerebral infarction. Methods Sixty patients with acute cerebral infarction confirmed by head CT scan from September 2014 to March 2015 were divided into two groups according to the treatment regimen: 30 cases in each group, the control group oral clopidogrel, the intervention group with lamp Asarum injection, the clinical efficacy of two groups were compared. Results The total effective rate (93.3%) in intervention group was higher than that in control group (66.7%), the difference was statistically significant (χ2 = 5.104, P <0.05). The NIHSS score of the intervention group after treatment was lower than that of the control group, with significant difference (P <0.05). Conclusion Erigeron breviscapus injection and clopidogrel treatment of acute cerebral infarction can significantly improve its clinical efficacy and improve neurological deficit, it is worthy of clinical promotion and application.